Smooth muscular tumours: the “time-in-time bomb” hidden in the body

Smooth muscular tumours: the “time-in-time bomb” hidden in the body

A smooth muscular tumor, a malignant tumour originating in a smooth muscle cell, which is not as well known as lung and stomach cancer, poses a serious threat to the health of the patient because of its high degree of malignity and complexity, such as a “time bomb” hidden in the body.

Smooth muscles are widely distributed in many organs and tissues of the human body, such as gastrointestinal tracts, uterus, vascular walls, etc. When the smoothing muscle cells of these parts change badly, they can create smooth muscle tumors. Unlike benign smooth muscle tumours, smooth muscle tumours have invasive growth and transfer properties. It is not content to grow “in one’s own right” in its original place, but rather to spread to the surrounding tissues and organs, like the greedy aggressors, and to destroy normal organizational and physiological functions.

The harm of smoothing muscle tumours begins with local oppression and destruction. For example, smooth muscular tumors in the gastrointestinal tract, which, as the tumor increases, gradually oppress the cavity of the gastrointestinal tract, lead to food passage being obstructed and patients may experience a series of digestive system symptoms such as nausea, vomiting, abdominal pain, abdominal swelling, constipation or diarrhoea. If tumours violate the blood vessels of the gastrointestinal tract, they can also cause haemorrhage, which can lead to haemorrhage in serious cases and endanger life. A smooth muscular tumor in the uterus may affect the normal contraction of the uterus, leading to more months, longer menstruation and even serious complications such as uterus rupture.

Worse still, smooth muscle tumors have the ability to transfer. It can sow tumour cells to other parts of the body, such as lungs, liver, bones, etc., through blood circulation or lymphocyte systems. Once the transfer occurs, the difficulty of treatment will increase significantly and the patient ‘ s prognosis will become poor. Oncological cells that are transferred to the lung form new stoves to the lung, which affect the gas exchange function of the lung, and the patient may suffer from symptoms such as cough, crayoma, respiratory difficulties; transfer to the liver interferes with liver metabolism, detoxification, etc. resulting in yellow salivation, abdominal water, liver failure, etc.; and transfer to the bone causes bone pain, diseaseal fractures, etc., which seriously affect the patient ‘ s quality of life and mobility.

The causes of smooth muscular tumors are not yet fully identified, but studies have found that some factors may be relevant. Long-term chronic inflammation is likely to be one of the contributing factors to muscular cell malformations, such as chronic inflammation in the gastrointestinal tract and chronic diseases in the uterus. In addition, certain genetic mutations, radiation exposure, long-term exposure to chemicals, etc. may have played a role in smoothing the development of muscle tumors. However, for the majority of patients, it is difficult to determine which particular factors cause the disease.

Since the early symptoms of smooth muscle tumours are often not specific, they can easily be ignored or misdiagnosed as other benign diseases, which also results in many patients being in the middle and late stages of the disease at the time of diagnosis and missing the best treatment. Diagnosis of smooth muscular tumors usually requires a combination of a variety of screening methods, including visual examinations (e.g. ultrasound, CT, MRI, etc.), pathological biopsies, etc. The pathological biopsy is the key to the diagnosis, and it is possible to determine the type, degree of fragmentation, etc. of the tumour cells by making a microscopy of the tumour tissue, thus providing an important basis for the development of treatment programmes.

The treatment of smooth muscular tumours is mainly based on surgical hysterectomy, and for early limited tumours, complete tumour tumour ectomy can increase the survival of patients to some extent. However, due to the tumour infestation and transferability, surgery often makes it difficult to completely remove all tumour cells and has a high rate of post-operative recurrence. As a result, there is usually a need for a combination of complementary treatments, such as chemotherapy and decomposition, to kill residual tumour cells and reduce the risk of relapse and diversion. However, the effects of chemotherapy and treatment vary considerably from one patient to another, and these treatments themselves have a number of side effects, such as nausea, vomiting, hair loss, bone marrow inhibition, etc., and cause the patient double physical and psychological suffering.

A smooth muscular tumor is a very dangerous malignant tumor that not only causes severe damage to the organs of the original hair but also threatens the health of multiple systems through transfer. Knowledge of the disease and increased vigilance about its early symptoms are of crucial importance for early diagnosis, timely treatment and improved patient prognosis. At the same time, medical research is continuing its efforts to explore its mechanisms for morbidity and more effective treatment, in the hope that in the future it will bring more hope and life to patients.

A smooth muscle tumor.